Valuation Alkem Laboratories Limited

Stocks

Market Closed - NSE India S.E. 15:05:06 12/10/2026 +04			5-day change	1st Jan Change
5,205.00 ^INR	-1.40%		-0.29%	-5.48%

09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Key Managerial Personnel and Senior Management Personnel, Effective September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	432,909	406,055	590,890	583,680	633,575	622,336	-	-
Change	-	-6.2%	45.52%	-1.22%	8.55%	-1.77%	-	-
Enterprise Value (EV) ¹	433,805	393,853	587,236	578,678	632,481	609,211	594,151	584,955
Change	-	-9.21%	49.1%	-1.46%	9.3%	-3.68%	-2.47%	-1.55%
P/E	26.3x	41.3x	32.9x	27x	27.5x	27.2x	23.6x	20.3x
PBR	5.01x	4.49x	5.73x	4.87x	4.58x	4.02x	3.55x	3.13x
PEG	-	-1x	0.4x	1.3x	4.37x	-63.38x	1.5x	1.3x
Capitalization / Revenue	4.07x	3.5x	4.66x	4.5x	4.31x	3.73x	3.35x	3.04x
EV / Revenue	4.08x	3.4x	4.64x	4.46x	4.3x	3.65x	3.19x	2.86x
EV / EBITDA	21.1x	24.5x	26.2x	23x	21x	17.8x	15.1x	13.2x
EV / EBIT	24.8x	30.3x	30.2x	26.9x	24.1x	20.6x	17.4x	14.9x
EV / FCF	55.4x	27.1x	33.3x	45.3x	42.8x	59.1x	29.1x	22.9x
FCF Yield	1.81%	3.69%	3%	2.21%	2.33%	1.69%	3.44%	4.36%
Dividend per Share ²	34	25	40	45	53	50.29	55.4	63.85
Rate of return	0.94%	0.74%	0.81%	0.92%	1%	0.97%	1.06%	1.23%
EPS ²	137.6	82.31	150.2	181.1	192.5	191.7	221	256.1
Distribution rate	24.7%	30.4%	26.6%	24.8%	27.5%	26.2%	25.1%	24.9%
Net sales ¹	106,342	115,993	126,676	129,645	147,123	166,970	186,008	204,727
EBITDA ¹	20,529	16,094	22,455	25,122	30,052	34,183	39,337	44,427
EBIT ¹	17,490	12,990	19,462	21,550	26,232	29,608	34,151	39,180
Net income ¹	16,456	9,842	17,958	21,655	23,018	23,096	27,276	31,030
Net Debt ¹	896.1	-12,202	-3,654	-5,003	-1,094	-13,125	-28,185	-37,381
Reference price ²	3,620.70	3,396.10	4,942.00	4,881.70	5,299.00	5,205.00	5,205.00	5,205.00
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,565	-	-
Announcement Date	13/05/22	19/05/23	29/05/24	29/05/25	28/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALKEM LABORATORIES LIMITED	27.54x	3.7x	18.08x	0.95%	6.52B
ELI LILLY AND COMPANY	33.55x	12.18x	25.21x	0.58%	1,051B
JOHNSON & JOHNSON	29x	6.42x	18.31x	2.04%	630B
ABBVIE INC.	35.19x	8.13x	16.76x	2.51%	489B
MERCK & CO., INC.	111.24x	5.93x	25.27x	2.34%	359B
ROCHE HOLDING AG	19.31x	4.72x	11.72x	2.8%	344B
NOVARTIS AG	20.06x	5.27x	12.98x	3.02%	272B
ASTRAZENECA PLC	20.56x	4.21x	12.07x	2.1%	246B
AMGEN INC.	26.34x	6.83x	12.21x	2.43%	224B
GILEAD SCIENCES, INC.	-45.84x	6.75x	26.31x	2.18%	187B
Average	27.70x	6.41x	17.89x	2.1%	381.02B
Weighted average by Cap.	32.90x	7.84x	19.33x	1.9%